State of Wyoming’s Corcept Therapeutics CORT Stock Holding History

State of Wyoming’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-816	Closed	-$32.9K	–	1966
2026 Q1	$32.9K	Buy	816 +186	+30%	+$6.96K	﹤0.01%	1618
2025 Q4	$21.9K	Buy	+630	New	+$49.5K	﹤0.01%	1686
2024 Q4	–	Sell	-1,519	Closed	-$70.3K	–	1656
2024 Q3	$70.3K	Sell	1,519 -4,367	-74%	-$155K	0.01%	1300
2024 Q2	$191K	Sell	5,886 -3,955	-40%	-$108K	0.03%	594
2024 Q1	$248K	Sell	9,841 -65	-0.7%	-$1.54K	0.04%	458
2023 Q4	$322K	Buy	+9,906	New	+$272K	0.06%	274
2023 Q3	–	Sell	-5,004	Closed	-$111K	–	1666
2023 Q2	$111K	Buy	5,004 +2,289	+84%	+$52.7K	0.03%	777
2023 Q1	$58.8K	Buy	+2,715	New	+$59.5K	0.02%	1047
2022 Q3	–	Sell	-1,719	Closed	-$41K	–	1596
2022 Q2	$41K	Sell	1,719 -1,387	-45%	-$30.2K	0.03%	1065
2022 Q1	$70K	Sell	3,106 -2,514	-45%	-$53.5K	0.04%	835
2021 Q4	$111K	Buy	+5,620	New	+$114K	0.05%	544

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State of Wyoming's CORT Position: Q2 2026 in Review

State of Wyoming sold out of Corcept Therapeutics (CORT) in Q2 2026, closing a stake of 816 shares — an estimated $32.9K sold.

State of Wyoming first reported a position in CORT in Q4 2021 and held it in 11 quarters. The position peaked at $322K in Q4 2023. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

State of Wyoming reported no remaining Corcept Therapeutics position as of Q2 2026 after selling out during the quarter.
State of Wyoming sold 816 Corcept Therapeutics shares in Q2 2026, an estimated $32.9K.
State of Wyoming first reported a position in Corcept Therapeutics in Q4 2021 and held it in 11 quarters.
State of Wyoming's Corcept Therapeutics position peaked at $322K in Q4 2023.
423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.